Publications
Download CSV
Download XLSX
Download TXT
Tables
2024 (842)
2023 (887)
2022 (831)
2021 (892)
2020 (640)
2019 (727)
2018 (651)
2017 (681)
2016 (664)
2015 (429)
2014 (376)
2013 (319)
2012 (244)
2011 (163)
2010 (139)
2000 (2)
1977 (2)
All (8489)
Infrastructure Units
Infrastructure Units list
Infrastructure Units table
Researchers
Subset
Documentation
About
Contact
Software
Login
Huseby DL
JSON
CSV
XLSX
TXT
Family name
Huseby
Given name
Douglas L
Initials
DL
ORCID
ORCID
0000-0001-9974-578X
Affiliations
Department of Medical Biochemistry and Microbiology, Uppsala University, Husargatan 3, 75123 Uppsala, Sweden.
3 publications
PubMed
DOI
Crossref
Antibiotic class with potent in vivo activity targeting lipopolysaccharide synthesis in Gram-negative bacteria.
Huseby DL
, Cao S,
Zamaratski E
, ...,
Hughes D
,
Karlén A
Proc. Natl. Acad. Sci. U.S.A.
121
(15) e2317274121 [2024-04-09; online 2024-04-05]
Drug Discovery and Development (DDD) [Collaborative]
PubMed
DOI
Crossref
New Dual Inhibitors of Bacterial Topoisomerases with Broad-Spectrum Antibacterial Activity and In Vivo Efficacy against Vancomycin-Intermediate Staphylococcus aureus.
Durcik M
,
Cotman AE
, Toplak Ž, ...,
Tomašič T
,
Peterlin Mašič L
J. Med. Chem.
66
(6) 3968-3994 [2023-03-23; online 2023-03-06]
Drug Discovery and Development (DDD) [Service]
PubMed
DOI
Crossref
Discovery and Hit-to-Lead Optimization of Benzothiazole Scaffold-Based DNA Gyrase Inhibitors with Potent Activity against Acinetobacter baumannii and Pseudomonas aeruginosa.
Cotman AE
,
Durcik M
, Benedetto Tiz D, ..., Sterk GJ, Kikelj D
J. Med. Chem.
66
(2) 1380-1425 [2023-01-26; online 2023-01-12]
Drug Discovery and Development (DDD) [Service]
SciLifeLab Data Centre
Publications
9.5.1